Scholar Rock Holding (SRRK) Total Current Liabilities (2017 - 2026)

Scholar Rock Holding's (SRRK) quarterly Total Current Liabilities came in at $59.6 million in Q1 2026, up 58.73% year-on-year from $37.6 million in Q1 2025, and up 7.62% quarter-over-quarter from $55.4 million in Q4 2025.

Scholar Rock Holding (SRRK) Total Current Liabilities (2017 - 2026) Analysis & Trends

Scholar Rock Holding's Total Current Liabilities history runs 10 years deep, the most recent figure standing at $59.6 million for Q1 2026.

  • On a quarterly basis, Total Current Liabilities rose 58.73% year-over-year to $59.6 million in Q1 2026; TTM through Mar 2026 was $59.6 million, a 58.73% increase from a year earlier, with the FY2025 full-year figure at $55.4 million, up 18.07% from the prior year.
  • Total Current Liabilities climbed to $59.6 million in Q1 2026 per SRRK's latest filing, from $55.4 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $62.0 million in Q3 2025 and bottomed at $24.3 million in Q2 2023.
  • The 5-year median for Total Current Liabilities is $37.5 million (2024), against an average of $39.7 million.
  • Across the five-year window, Total Current Liabilities slumped 52.29% in 2022 and soared 58.73% in 2026, its largest moves.
  • Year by year, Total Current Liabilities stood at $36.4 million in 2022, then declined by 10.03% to $32.7 million in 2023, then soared by 43.36% to $46.9 million in 2024, then advanced by 18.07% to $55.4 million in 2025, then advanced by 7.62% to $59.6 million in 2026.
  • Per Business Quant, the three latest SRRK Total Current Liabilities figures stand at $59.6 million (Q1 2026), $55.4 million (Q4 2025), and $62.0 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 56.01 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 66.94 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.81 Bn
4 NuCana 279.75 Bn 279.75 Bn - 6.38 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 3.88 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 5.11 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.58 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 289.60 Mn
10 Scholar Rock Holding 6.30 Bn 6.30 Bn - 59.64 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 59.64 Mn
Dec 31, 2025 55.42 Mn
Sep 30, 2025 61.97 Mn
Jun 30, 2025 50.44 Mn
Mar 31, 2025 37.57 Mn
Dec 31, 2024 46.94 Mn
Sep 30, 2024 39.37 Mn
Jun 30, 2024 32.99 Mn
Mar 31, 2024 37.51 Mn
Dec 31, 2023 32.74 Mn
Sep 30, 2023 26.73 Mn
Jun 30, 2023 24.27 Mn
Mar 31, 2023 26.21 Mn
Dec 31, 2022 36.39 Mn
Sep 30, 2022 33.74 Mn
Jun 30, 2022 40.16 Mn
Mar 31, 2022 33.37 Mn
Dec 31, 2021 64.30 Mn
Sep 30, 2021 64.60 Mn
Jun 30, 2021 67.02 Mn